Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer

NCT02698891 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Early Stage Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Neulasta

Sponsor

Dana-Farber Cancer Institute